Environmental origins of congenital heart disease: The heart-placenta connection

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 5, 2013, Pages 245-250

  Huhta, James ^a   Linask, Kersti K ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Birth defects; Cardiac embryonic development; Congenital heart disease; Fetal echocardiography; Folate

Indexed keywords

ALCOHOL; ENVIRONMENTAL CHEMICAL; HOMOCYSTEINE; LITHIUM;

BIRTH DEFECT; CARDIOVASCULAR MALFORMATION; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; COLOR ULTRASOUND FLOWMETRY; CONGENITAL HEART DISEASE; DNA METHYLATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; EMBRYO CELL; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; FETUS ECHOGRAPHY; FETUS GROWTH; GENE MUTATION; GENETIC VARIABILITY; HEART DEVELOPMENT; HEART FUNCTION; HEART OUTPUT; HIGH RISK PREGNANCY; HUMAN; INFANT MORTALITY; MATERNAL NUTRITION; NEURAL TUBE DEFECT; NONHUMAN; NUTRITIONAL DISORDER; PLACENTA FUNCTION; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; REVIEW; WELLBEING;

BIRTH DEFECTS; CARDIAC EMBRYONIC DEVELOPMENT; CONGENITAL HEART DISEASE; FETAL ECHOCARDIOGRAPHY; FOLATE;

ANIMALS; DIETARY SUPPLEMENTS; ENVIRONMENTAL ILLNESS; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; FETAL HEART; FOLIC ACID; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PLACENTA; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 84884357215     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.05.003     Document Type: Review

References (92)

1. Fahed A.C., Gelb B.D., Seidman J.G., Seidman C.E. Genetics of congenital heart disease: the glass half empty. Circ Res 2013, 112:707-720.
2. Ohtani K., Dimmeler S. Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 2011, 106:5-11.
3. Chang C.P., Bruneau B.G. Epigenetics and cardiovascular development. Annu Rev Physiol 2012, 74:41-68.
4. Kubicek S., Schotta G., Lachner M., et al. The role of histone modifications in epigenetic transitions during normal and perturbed development. Ernst Schering Res Found Workshop 2006, 57:1-27.
5. Burd L., Deal E., Rios R., Adickes E., Wynne J., Klug M.G. Congenital heart defects and fetal alcohol spectrum disorders. Congen Heart Dis 2007, 2:250-255.
6. Yoon P.W., Olney R.S., Khoury M.J., Sappenfield W.M., Chavez G.F., Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med 1997, 151:1096-1103.
7. Larsen W.J. Human embryology 1993, Churchill Livingstone, New York.
8. Bailey B., Sokol R. Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol 2008, 51:436-444.
9. Bruyere H.J., Stith C.E. Strain-dependent effect of ethanol on ventricular septal defect frequency in White Leghorn chick embryos. Teratology 1993, 48:299-303.
10. Smith S.M. The avian embryo in fetal alcohol research. Methods Mol Biol 2008, 447:75-84.
11. Chen J., Han M., Manisastry S.M., et al. Molecular effects of lithium exposure during mouse and chick gastrulation and subsequent valve dysmorphogenesis. Birth Defects Res A Clin Mol Teratol 2008, 82:508-518.
12. Serrano M., Han M., Brinez P., Linask K.K. Fetal alcohol syndrome: cardiac birth defects in mice and prevention with folate. Am J Obstet Gynecol 2010, 203:75.e7-75.e15.
13. Maurano M.T., Humbert R., Rynes E., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
14. Barker D.J. The origins of the developmental origins theory. JIntern Med 2007, 261:412-417.
15. Barker D.J. Human growth and cardiovascular disease. Nestle Nutr Workshop Ser Pediatr Program 2008, 61:21-38.
16. Barker D.J., Bergmann R.L., Ogra P.L. Concluding remarks. The window of opportunity: pre-pregnancy to 24 months of age. Nestle Nutr Workshop Ser Pediatr Program 2008, 61:255-260.
17. Adams R., Porras A., Alonso G., Jones M., Vintersten K., Panelli S., et al. Essential role of p38 alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000, 6:109-116.
18. Barak Y., Nelson M., Ong E., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999, 4:585-595.
19. Cross J.C., Mickelson L. Nutritional influences on implantation and placental development. Nutr Rev 2006, 64:S12-S18. discussion S72-91.
20. Hemberger M., Cross J. Genes governing placental development. Trends Endocrinol Metab 2001, 12:162-168.
21. Clark J., Anderson K.E., Juvin V., et al. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods 2011, 8:267-272.
22. Monkley S.J., Delaney S.J., Pennisi D.J., Christiansen J.H. Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996, 122:3343-3353.
23. Peng S., Li J., Miao C., et al. Dickkopf-1 secreted by decidual cells promotes trophoblast cell invasion during murine placentation. Reproduction 2008, 135:367-375.
24. Han M., Neves A.L., Serrano M., et al. Effects of alcohol, lithium, and homocysteine on nonmuscle myosin-II in the mouse placenta and human trophoblasts. Am J Obstet Gynecol 2012, 207:140.e7-140.e719.
25. Han M., Serrano M.C., Lastra-Vicente R., et al. Folate rescues lithium-, homocysteine- and Wnt3A-induced vertebrate cardiac anomalies. Dis Model Mech 2009, 2:467-478.
26. Linask K.K., Huhta J. Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr 2010, 22:561-566.
27. Serrano M., Han M., Huhta J.C.L., Lastra R., Garita B., Linask K.K. Folate suppresses Wnt/β-catenin inhibition of cardiogenesis to protect against induction of congenital heart defects. Circulation 2008, 118. S419 (Abstract 3408).
28. Serrano M.C., Linask K.K., Acharya G., Chen J., Han M., Huhta J.C. One-time lithium dose in early gestation causes placental and cardiac dysfunction. Am J Obstet Gynecol 2007, 195:210. P698.
29. Acharya G., Erkinaro T., Makikallio K., Lappalainen T., Rasanen J. Relationships among Doppler-derived umbilical artery absolute velocities, cardiac function, and placental volume blood flow and resistance in fetal sheep. Am J Physiol Heart Circ Physiol 2004, 286:H1266-H1272.
30. Acharya G., Wilsgaard T., Berntsen G., Maltau J., Kiserud T. Reference ranges for serial measurements of blood velocity and pulsatility index at the intra-abdominal portion, and fetal and placental ends of the umbilical artery. Ultrasound Obstet Gynecol 2005, 26:162-169.
31. Archer J.M., Yeager S.B., Kenny M.J., Soll R.F., Horbar J.D. Distribution of and mortality from serious congenital heart disease in very low birth weight infants. Pediatrics 2011, 127:293-299.
32. Rozmus-Warcholinska W., Wloch A., Acharya G., et al. Reference values for variables of fetal cardiocirculatory dynamics at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2010, 35:540-547.
33. Kaukola T., Rasanen J., Herva R., Patel D.D., Hallman M. Suboptimal neurodevelopment in very preterm infants is related to fetal cardiovascular compromise in placental insufficiency. Am J Obstet Gynecol 2005, 193:414-420.
34. Miller A., Riehle-Colarusso T., Alverson C., Frias J., Correa A. Congenital heart defects and major structural noncardiac anomalies, Atlanta, Georgia, 1968-2005. JPediatr 2011, 159:70-78.
35. Giles S., Boehm P., Brogan C., Bannigan J. The effects of ethanol on CNS development in the chick embryo. Reprod Toxicol 2008, 25:224-230.
36. Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Perinatol 2001, 28:1-10.
37. Nath A.K., Krauthammer M., Li P., et al. Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defects. PLoS One 2009, 4. e4221.
38. Bovill E., Westaby S., Reji S., Sayeed R., Crisp A., Shaw T. Induction by left ventricular overload and left ventricular failure of the human Jumonji gene (JARID2) encoding a protein that regulates transcription and reexpression of a protective fetal program. JThorac Cardiovasc Surg 2008, 136:709-716.
39. Long J., Lupo P.J., Goldmuntz E., Mitchell L.E. Evaluation of heterogeneity in the association between congenital heart defects and variants of folate metabolism genes: conotruncal and left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol 2011, 91:879-884.
40. Goldmuntz E., Woyciechowski S., Renstrom D., Lupo P.J., Mitchell L.E. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 2008, 1:126-132.
41. Hove J.R., Koster R.W., Forouhar A.S., Acevedo-Bolton G., Fraser S.E., Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 142:172-177.
42. Sedmera D. Form follows function: developmental and physiological view on ventricular myocardial architecture. Eur J Cardiothorac Surg 2005, 28:526-528.
43. Garita B., Jenkins M., Han M., et al. Blood flow dynamics of one cardiac cycle and relationship to mechanotransduction and trabeculation during heart looping. Am J Physiol Heart Circ Physiol 2011, 300:H879-H891.
44. Linask K.K., Vanauker M. Arole for the cytoskeleton in heart looping. ScientificWorldJournal 2007, 7:280-298.
45. Groenendijk B., Hierck B., Gittenberger-de-Groot A., Poelmann R. Development-related changes in the expression of shear stress responsive genes KLF-2, ET-1, and NOS-3 in the developing cardiovascular system of chicken embryos. Dev Dyn 2004, 230:57-68.
46. Groenendijk B.C., Hierck B.P., Vrolijk J., et al. Changes in shear stress-related gene expression after experimentally altered venous return in the chicken embryo. Circ Res 2005, 96:1291-1298.
47. Moore K.L., Persaud T.V.N. The developing human: clinically oriented embryology 2003, Saunders, Philadelphia.
48. Manisastry S.M., Han M., Linask K.K. Early temporal-specific responses and differential sensitivity to lithium and Wnt-3A exposure during heart development. Dev Dyn 2006, 235:2160-2174.
49. Kwon C., Arnold J., Hsiao E.C., Taketo M.M., Conklin B.R., Srivastava D. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA 2007, 104:10894-10899.
50. Kwon C., Cordes K.R., Srivastava D. Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis. Cell Cycle 2008, 7:3815-3818.
51. Linask K.K., Knudsen K.A., Gui Y.H. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol 1997, 185:148-164.
52. Ueno S., Weidinger G., Osugi T., et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007, 104:6685-9690.
53. Pollheimer J., Loregger T., Sonderegger S., Saleh L., Bauer S., Bilban M., et al. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 2006, 168:1134-1147.
54. Sonderegger S., Husslein H., Leisser C., Knofler M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007, 28(Suppl. A):S97-S102.
55. Garcia-Castro M.I., Marcelle C., Bronner-Fraser M. Ectodermal Wnt function as a neural crest inducer. Science 2002, 297:848-851.
56. Knecht A.K., Bronner-Fraser M. Induction of the neural crest: a multigene process. Nat Rev Genet 2002, 3:453-461.
57. Ruffins S., Bronner-Fraser M. Acritical period for conversion of ectodermal cells to a neural crest fate. Dev Biol 2000, 218:13-20.
58. Waldo K., Hutson M., Ward C., et al. Secondary heart field contributes myocardium and smooth muscle to the arterial. Dev Biol 2005, 281:78-90.
59. Waldo K.L., Kumiski D.H., Wallis K.T., et al. Conotruncal myocardium arises from a secondary heart field. Development 2001, 128:3179-3188.
60. de la Cruz M.V., Sanchez-Gomez C. Straight tube heart. Primitive cardiac cavities vs. primitive cardiac segments. Living morphogenesis of the heart 1998, 85-98. Birkhauser, Boston. M.V. de la Cruz, R.R. Markwald (Eds.).
61. Markwald R.R., Nakaoka T., Mjaatvedt C.H. Overview: formation of the primary heart tube. Etiology and morphogenesis of congenital heart disease: twenty years of progress in genetics and developmental biology 2000, 103-114B. Futura Publishing, Armonk, NY. E.B. Clark, M. Nakazawa, A. Takao (Eds.).
62. Linask K., Gui Y.H., Rasheed R., Kwon L. Pattern development during pericardial coelom formation and specification of the cardiomyocyte cell population by N-cadherin and the Drosophila armadillo protein homologue in the early chick embryo. Mol Biol Cell 1992, 3(Suppl.):206A.
63. Linask K.K. Regulation of heart morphology: current molecular and cellular perspectives on the coordinated emergence of cardiac form and function. Birth Defects Res C Embryo Today 2003, 69:14-24.
64. Cai C.L., Liang X., Shi Y., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5:877-889.
65. Verzi M.P., McCulley D.J., De Val S., Dodou E., Black B.L. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. Dev Biol 2005, 287:134-145.
66. Loffredo C.A. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet 2000, 97:319-325.
67. Kirby M.L., Lawson A., Stadt H.A., et al. Hensen's node gives rise to the ventral midline of the foregut: implications for organizing head and heart development. Dev Biol 2003, 253:175-188.
68. Pera E.M., De Robertis E.M. Adirect screen for secreted proteins in Xenopus embryos identifies distinct activities for the Wnt antagonists Crescent and Frzb-1. Mech Dev 2000, 96:183-195.
69. Schier A.F., Neuhauss S.C., Helde K.A., Talbot W.S., Driever W. The one-eyed pinhead gene functions in mesoderm and endoderm formation in zebrafish and interacts with no tail. Development 1997, 124:327-342.
70. Seifert R., Jacob M., Jacob H.J. The avian prechordal head region: a morphological study. JAnat 1993, 183(Pt 1):75-89.
71. Wessels A., Anderson R.H., Markwald R.R., et al. Atrial development in the human heart: an immunohistochemical study with emphasis on the role of mesenchymal tissues. Anat Rec 2000, 259:288-300.
72. Anderson R.H., Webb S., Brown N.A., Lamers W.H., Moorman A. Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks. Heart 2003, 89:1110-1118.
73. Snarr B.S., Wirrig E.E., Phelps A.L., Trusk T.C., Wessels A. Aspatiotemporal evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac development. Dev Dyn 2007, 236:1287-1294.
74. Lincoln J., Lange A.W., Yutzey K.E. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol 2006, 294:292-302.
75. Lincoln J., Yutzey K.E. Molecular and developmental mechanisms of congenital heart valve disease. Birth Defects Res A Clin Mol Teratol 2011, 91:526-534.
76. Cains S., Shepherd A., Nabiuni M., Owen-Lynch P.J., Miyan J. Addressing a folate imbalance in fetal cerebrospinal fluid can decrease the incidence of congenital hydrocephalus. JNeuropathol Exp Neurol 2009, 68:404-416.
77. De-Regil L.M., Fernandez-Gaxiola A.C., Dowswell T., Pena-Rosas J.P. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010, 10. CD007950.
78. Rosano A., Smithells D., Cacciani L., et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. JEpidemiol Community Health 1999, 53:630-635.
79. Thompson S., Torres M., Stevenson R., Dean J., Best R. Periconceptional vitamin use, dietary folate and occurrent neural tube defected pregnancies in a high risk population. Ann Epidemiol 2000, 10:476.
80. Ionescu-Ittu R., Marelli A., Mackie A., Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 2009, 338. b1673.
81. Czeizel A. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996, 62:179-183.
82. Czeizel A.E., Puho E.H., Langmar Z., Acs N., Banhidy F. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur J Obstet Gynecol Reprod Biol 2010, 148:135-140.
83. Pickell L., Brown K., Li D., et al. High intake of folic acid disrupts embryonic development in mice. Birth Defects A 2011, 91:8-19.
84. Aguilera O., Fernandez A.F., Munoz A., Fraga M.F. Epigenetics and environment: a complex relationship. JAppl Phys 2010, 109:243-251.
85. Bollati V., Baccarelli A. Environmental epigenetics. Heredity 2010, 105:105-112.
86. Villeneuve L., Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010, 299:F14-F25.
87. Foley A.C., Mercola M. Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev 2005, 19:387-396.
88. Broun M., Gee L., Reinhardt B., Bode H.R. Formation of the head organizer in hydra involves the canonical Wnt pathway. Development 2005, 132:2907-2916.
89. Carmona-Fontaine C., Matthews H.K., Kuriyama S., et al. Contact inhibition of locomotion invivo controls neural crest directional migration. Nature 2008, 456:957-961.
90. Chacon M.A., Varela-Nallar L., Inestrosa N.C. Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers. JCell Physiol 2008, 217:215-227.
91. Nafee T.M., Farrell W.E., Carroll W.D., Fryer A.A., Ismail K.M. Epigenetic control of fetal gene expression. BJOG 2008, 115:158-168.
92. Kiefer J. Epigenetics in development. Dev Dyn 2007, 236:1144-1156.